Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, in which patient groups will recommendations for combining GLP-1 receptor agonists with SGLT2 inhibitors be included as part of the updated NG28 guidelines.

The National Institute for Health and Care Excellence (NICE) develops its guidelines independently based on a thorough assessment of the available evidence and through extensive engagement with stakeholders.

The NICE’s independent committee is currently updating its clinical guideline recommendations on the use of medicines for the management of type 2 diabetes in adults. The draft recommendations will be issued for public consultation at the earliest opportunity. It is not possible to say what those recommendations will be at this time.